<VariationArchive VariationID="4087" VariationName="NM_000112.4(SLC26A2):c.1724del (p.Lys575fs)" VariationType="Deletion" Accession="VCV000004087" Version="19" RecordType="classified" NumberOfSubmissions="11" NumberOfSubmitters="9" DateLastUpdated="2024-06-17" DateCreated="2013-07-24" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="19126" VariationID="4087">
      <GeneList>
        <Gene Symbol="SLC26A2" FullName="solute carrier family 26 member 2" GeneID="1836" HGNC_ID="HGNC:10994" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>5q32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="149960758" stop="149987400" display_start="149960758" display_stop="149987400" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="149340299" stop="149366962" display_start="149340299" display_stop="149366962" Strand="+" />
          </Location>
          <OMIM>606718</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000112.4(SLC26A2):c.1724del (p.Lys575fs)</Name>
      <CanonicalSPDI>NC_000005.10:149981315:AA:A</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>5q32</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="149981316" stop="149981316" display_start="149981316" display_stop="149981316" variantLength="1" positionVCF="149981315" referenceAlleleVCF="TA" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="149360879" stop="149360879" display_start="149360879" display_stop="149360879" variantLength="1" positionVCF="149360878" referenceAlleleVCF="TA" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>K575fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.10" sequenceAccession="NC_000005" sequenceVersion="10" change="g.149981317del" Assembly="GRCh38">
            <Expression>NC_000005.10:g.149981317del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.9" sequenceAccession="NC_000005" sequenceVersion="9" change="g.149360880del" Assembly="GRCh37">
            <Expression>NC_000005.9:g.149360880del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007147.2" sequenceAccession="NG_007147" sequenceVersion="2" change="g.22435del">
            <Expression>NG_007147.2:g.22435del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000112.4" sequenceAccession="NM_000112" sequenceVersion="4" change="c.1724del" MANESelect="true">
            <Expression>NM_000112.4:c.1724del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000103.2" sequenceAccession="NP_000103" sequenceVersion="2" change="p.Lys575fs">
            <Expression>NP_000103.2:p.Lys575fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_684" sequenceAccession="LRG_684">
            <Expression>LRG_684:g.22435del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_684t1" sequenceAccession="LRG_684t1">
            <Expression>LRG_684t1:c.1724del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_684p1" sequenceAccession="LRG_684p1" change="p.Lys575fs">
            <Expression>LRG_684p1:p.Lys575fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000112.4" sequenceAccession="NM_000112" sequenceVersion="4" change="c.1724delA" MANESelect="true">
            <Expression>NM_000112.4:c.1724delA</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000112.3" sequenceAccession="NM_000112" sequenceVersion="3" change="c.1724delA">
            <Expression>NM_000112.3:c.1724delA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA252988" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="606718.0001" DB="OMIM" />
        <XRef Type="rs" ID="386833498" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence information reported in PubMed 7923357 Fig. 6 to determine the location of this allele on the current reference sequence. </Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000112.4(SLC26A2):c.1724del (p.Lys575fs) AND Diastrophic dysplasia" Accession="RCV000004302" Version="7">
        <ClassifiedConditionList TraitSetID="1119">
          <ClassifiedCondition DB="MedGen" ID="C0220726">Diastrophic dysplasia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1996-02-01" SubmissionCount="2">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000112.4(SLC26A2):c.1724del (p.Lys575fs) AND Atelosteogenesis type II" Accession="RCV000004303" Version="4">
        <ClassifiedConditionList TraitSetID="1120">
          <ClassifiedCondition DB="MedGen" ID="C1850554">Atelosteogenesis type II</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1996-02-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000112.4(SLC26A2):c.1724del (p.Lys575fs) AND Achondrogenesis, type IB" Accession="RCV000023567" Version="10">
        <ClassifiedConditionList TraitSetID="6557">
          <ClassifiedCondition DB="MedGen" ID="C0265274">Achondrogenesis, type IB</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-02-29" SubmissionCount="4">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000112.4(SLC26A2):c.1724del (p.Lys575fs) AND Sulfate transporter-related osteochondrodysplasia" Accession="RCV000586135" Version="1">
        <ClassifiedConditionList TraitSetID="7853">
          <ClassifiedCondition DB="MedGen" ID="CN120497">Sulfate transporter-related osteochondrodysplasia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-01-26" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000112.4(SLC26A2):c.1724del (p.Lys575fs) AND multiple conditions" Accession="RCV000817526" Version="7">
        <ClassifiedConditionList TraitSetID="12100">
          <ClassifiedCondition DB="MedGen" ID="C0265274">Achondrogenesis, type IB</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1850554">Atelosteogenesis type II</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0220726">Diastrophic dysplasia</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1847593">Multiple epiphyseal dysplasia type 4</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-12-14" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000112.4(SLC26A2):c.1724del (p.Lys575fs) AND Connective tissue disorder" Accession="RCV002276529" Version="3">
        <ClassifiedConditionList TraitSetID="40545">
          <ClassifiedCondition DB="MedGen" ID="C0009782">Connective tissue disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-05-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-02-29" NumberOfSubmissions="11" NumberOfSubmitters="9" DateCreated="2013-07-24" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">7923357</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8528239</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8571951</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8702127</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8723100</ID>
        </Citation>
        <DescriptionHistory Dated="2021-01-30">
          <Description>Pathogenic/Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2019-08-13">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2018-05-29">
          <Description>Pathogenic/Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="40545" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="36764" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Connective tissue disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Connective tissue disorder</ElementValue>
                <XRef ID="CMGVARID00030" DB="Centre for Mendelian Genomics, University Medical Centre Ljubljana" />
                <XRef ID="MONDO:0003900" DB="MONDO" />
              </Name>
              <XRef ID="C0009782" DB="MedGen" />
              <XRef ID="MONDO:0003900" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="12100" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="558" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Atelosteogenesis type II</ElementValue>
                <XRef ID="MONDO:0009727" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Neonatal osseous dysplasia 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">NEONATAL OSSEOUS DYSPLASIA I</ElementValue>
                <XRef Type="MIM" ID="256050" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Atelosteogenesis type 2</ElementValue>
                <XRef ID="Atelosteogenesis+Type+2/641" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">AOII</ElementValue>
                <XRef Type="MIM" ID="256050" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">AO2</ElementValue>
                <XRef Type="MIM" ID="256050" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8329" />
                <XRef ID="8329" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Clinical features of atelosteogenesis type 2 (AO2) include rhizomelic limb shortening with normal-sized skull, hitchhiker thumbs, small chest, protuberant abdomen, cleft palate, and distinctive facial features (midface retrusion, depressed nasal bridge, epicanthus, micrognathia). Other typical findings are ulnar deviation of the fingers, gap between the first and second toes, and clubfoot. AO2 is usually lethal at birth or shortly thereafter due to pulmonary hypoplasia and tracheobronchomalacia. However, it exists in a continuous phenotypic spectrum with diastrophic dysplasia, and long-term survivors have been reported.</Attribute>
                <XRef ID="NBK1317" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301493</ID>
                <ID Source="BookShelf">NBK1317</ID>
              </Citation>
              <XRef ID="56304" DB="Orphanet" />
              <XRef ID="C1850554" DB="MedGen" />
              <XRef ID="MONDO:0009727" DB="MONDO" />
              <XRef Type="MIM" ID="256050" DB="OMIM" />
            </Trait>
            <Trait ID="1181" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Multiple epiphyseal dysplasia type 4</ElementValue>
                <XRef ID="MONDO:0009189" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Multiple epiphyseal dysplasia, autosomal recessive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Multiple epiphyseal dysplasia with clubfoot</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Multiple epiphyseal dysplasia with double-layered patella</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Multiple epiphyseal dysplasia with bilayered patellae</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Multiple Epiphyseal Dysplasia, Recessive</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">EDM4</ElementValue>
                <XRef Type="MIM" ID="226900" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9793" />
                <XRef ID="9793" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Recessive multiple epiphyseal dysplasia (EDM4/rMED) is characterized by joint pain (usually in the hips or knees); malformations of hands, feet, and knees; and scoliosis. Approximately 50% of affected individuals have an abnormal finding at birth, e.g., clubfoot, clinodactyly, or (rarely) cystic ear swelling. Onset of articular pain is variable but usually occurs in late childhood. Stature is usually within the normal range prior to puberty; in adulthood, stature is only slightly diminished and ranges from 150 to 180 cm. Functional disability is mild.</Attribute>
                <XRef ID="NBK1306" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301483</ID>
                <ID Source="BookShelf">NBK1306</ID>
              </Citation>
              <XRef ID="93307" DB="Orphanet" />
              <XRef ID="C1847593" DB="MedGen" />
              <XRef ID="MONDO:0009189" DB="MONDO" />
              <XRef Type="MIM" ID="226900" DB="OMIM" />
            </Trait>
            <Trait ID="1977" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Diastrophic dysplasia</ElementValue>
                <XRef ID="Diastrophic+Dysplasia/2261" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009107" DB="MONDO" />
                <XRef ID="58561002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Diastrophic dwarfism</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DD</ElementValue>
                <XRef Type="MIM" ID="222600" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">DTD</ElementValue>
                <XRef Type="MIM" ID="222600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Diastrophic dysplasia (DTD) is characterized by limb shortening, normal-sized head, hitchhiker thumbs, spinal deformities (scoliosis, exaggerated lumbar lordosis, cervical kyphosis), and contractures of the large joints with deformities and early-onset osteoarthritis. Other typical findings are ulnar deviation of the fingers, gap between the first and second toes, and clubfoot. On occasion, the disease can be lethal at birth, but most affected individuals survive the neonatal period and develop physical limitations with normal intelligence.</Attribute>
                <XRef ID="NBK1350" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6275" />
                <XRef ID="6275" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301524</ID>
                <ID Source="BookShelf">NBK1350</ID>
              </Citation>
              <XRef ID="628" DB="Orphanet" />
              <XRef ID="C0220726" DB="MedGen" />
              <XRef ID="MONDO:0009107" DB="MONDO" />
              <XRef Type="MIM" ID="222600" DB="OMIM" />
            </Trait>
            <Trait ID="64" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Achondrogenesis, type IB</ElementValue>
                <XRef ID="Achondrogenesis+Type+1B/109" DB="Genetic Alliance" />
                <XRef ID="14870002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Achondrogenesis Fraccaro type</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ACG1B</ElementValue>
                <XRef Type="MIM" ID="600972" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="460" />
                <XRef ID="460" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Clinical features of achondrogenesis type 1B (ACG1B) include extremely short limbs with short fingers and toes, hypoplasia of the thorax, protuberant abdomen, and hydropic fetal appearance caused by the abundance of soft tissue relative to the short skeleton. The face is flat, the neck is short, and the soft tissue of the neck may be thickened. Death occurs prenatally or shortly after birth.</Attribute>
                <XRef ID="NBK1516" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301689</ID>
                <ID Source="BookShelf">NBK1516</ID>
              </Citation>
              <XRef ID="932" DB="Orphanet" />
              <XRef ID="93298" DB="Orphanet" />
              <XRef ID="C0265274" DB="MedGen" />
              <XRef ID="MONDO:0010966" DB="MONDO" />
              <XRef Type="MIM" ID="600972" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1120" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="558" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Atelosteogenesis type II</ElementValue>
                <XRef ID="MONDO:0009727" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Neonatal osseous dysplasia 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">NEONATAL OSSEOUS DYSPLASIA I</ElementValue>
                <XRef Type="MIM" ID="256050" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Atelosteogenesis type 2</ElementValue>
                <XRef ID="Atelosteogenesis+Type+2/641" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">AOII</ElementValue>
                <XRef Type="MIM" ID="256050" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">AO2</ElementValue>
                <XRef Type="MIM" ID="256050" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8329" />
                <XRef ID="8329" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Clinical features of atelosteogenesis type 2 (AO2) include rhizomelic limb shortening with normal-sized skull, hitchhiker thumbs, small chest, protuberant abdomen, cleft palate, and distinctive facial features (midface retrusion, depressed nasal bridge, epicanthus, micrognathia). Other typical findings are ulnar deviation of the fingers, gap between the first and second toes, and clubfoot. AO2 is usually lethal at birth or shortly thereafter due to pulmonary hypoplasia and tracheobronchomalacia. However, it exists in a continuous phenotypic spectrum with diastrophic dysplasia, and long-term survivors have been reported.</Attribute>
                <XRef ID="NBK1317" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301493</ID>
                <ID Source="BookShelf">NBK1317</ID>
              </Citation>
              <XRef ID="56304" DB="Orphanet" />
              <XRef ID="C1850554" DB="MedGen" />
              <XRef ID="MONDO:0009727" DB="MONDO" />
              <XRef Type="MIM" ID="256050" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1119" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="1977" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Diastrophic dysplasia</ElementValue>
                <XRef ID="Diastrophic+Dysplasia/2261" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009107" DB="MONDO" />
                <XRef ID="58561002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Diastrophic dwarfism</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DD</ElementValue>
                <XRef Type="MIM" ID="222600" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">DTD</ElementValue>
                <XRef Type="MIM" ID="222600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Diastrophic dysplasia (DTD) is characterized by limb shortening, normal-sized head, hitchhiker thumbs, spinal deformities (scoliosis, exaggerated lumbar lordosis, cervical kyphosis), and contractures of the large joints with deformities and early-onset osteoarthritis. Other typical findings are ulnar deviation of the fingers, gap between the first and second toes, and clubfoot. On occasion, the disease can be lethal at birth, but most affected individuals survive the neonatal period and develop physical limitations with normal intelligence.</Attribute>
                <XRef ID="NBK1350" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6275" />
                <XRef ID="6275" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301524</ID>
                <ID Source="BookShelf">NBK1350</ID>
              </Citation>
              <XRef ID="628" DB="Orphanet" />
              <XRef ID="C0220726" DB="MedGen" />
              <XRef ID="MONDO:0009107" DB="MONDO" />
              <XRef Type="MIM" ID="222600" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6557" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="64" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Achondrogenesis, type IB</ElementValue>
                <XRef ID="Achondrogenesis+Type+1B/109" DB="Genetic Alliance" />
                <XRef ID="14870002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Achondrogenesis Fraccaro type</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ACG1B</ElementValue>
                <XRef Type="MIM" ID="600972" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="460" />
                <XRef ID="460" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Clinical features of achondrogenesis type 1B (ACG1B) include extremely short limbs with short fingers and toes, hypoplasia of the thorax, protuberant abdomen, and hydropic fetal appearance caused by the abundance of soft tissue relative to the short skeleton. The face is flat, the neck is short, and the soft tissue of the neck may be thickened. Death occurs prenatally or shortly after birth.</Attribute>
                <XRef ID="NBK1516" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301689</ID>
                <ID Source="BookShelf">NBK1516</ID>
              </Citation>
              <XRef ID="932" DB="Orphanet" />
              <XRef ID="93298" DB="Orphanet" />
              <XRef ID="C0265274" DB="MedGen" />
              <XRef ID="MONDO:0010966" DB="MONDO" />
              <XRef Type="MIM" ID="600972" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="7853" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16780" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Sulfate transporter-related osteochondrodysplasia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">DTDST-related dysplasias</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000321063" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000525804" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000238852" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <XRef ID="CN120497" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="131219" SubmissionDate="2013-05-19" DateLastUpdated="2013-07-24" DateCreated="2013-07-24">
        <ClinVarSubmissionID localKey="FINDIS260" />
        <ClinVarAccession Accession="SCV000081859" DateUpdated="2013-07-24" DateCreated="2013-07-24" Type="SCV" Version="1" SubmitterName="Juha Muilu Group; Institute for Molecular Medicine Finland (FIMM)" OrgID="500116" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>probable-pathogenic</GermlineClassification>
          <Comment Type="ConvertedByNCBI">Converted during submission to Likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>not provided</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>not provided</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <CitationList>
            <Citation Type="general">
              <ID Source="PubMed">7923357</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">8723100</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">8702127</ID>
            </Citation>
          </CitationList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000112.3:c.1724delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Diastrophic dysplasia</ElementValue>
            </Name>
            <XRef DB="OMIM" ID="222600" Type="MIM" />
          </Trait>
        </TraitSet>
        <Comment Type="public">FinDis database variant: This variant was not found or characterized by our laboratory, data were collected from public sources: see reference</Comment>
        <SubmissionNameList>
          <SubmissionName>FinDis_mutations</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="24468" SubmissionDate="2015-04-06" DateLastUpdated="2015-04-08" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="606718.0001_DIASTROPHIC DYSPLASIA" title="SLC26A2, 1-BP DEL, 1751A_DIASTROPHIC DYSPLASIA" />
        <ClinVarAccession Accession="SCV000024468" DateUpdated="2015-04-08" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1996-02-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 3 patients with diastrophic dysplasia (DTD; 222600) from Germany, the Netherlands, and France, respectively, Hastbacka et al. (1994) identified heterozygosity for a deletion of 1 nucleotide in codon 575 of the DTD gene (SLC26A2), converting AAG to AG; this mutation resulted in a frameshift, causing a premature translational stop after 9 codons that would eliminate the last 20% of the protein. The deletion destroyed a DdeI site and created a BfaI site, providing a simple assay for the presence of the mutation. The patients presumably carried a different DTD mutation on the other homolog. Examination of 100 normal chromosomes confirmed that the deletion was not a polymorphism.</Attribute>
              <Citation>
                <ID Source="PubMed">7923357</ID>
              </Citation>
              <XRef DB="OMIM" ID="222600" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Superti-Furga et al. (1996) found that this mutation, which they called the 1751A deletion, results in diastrophic dysplasia when compounded with the presumed reduced-expression allele frequent in Finland (606718.0010), but produces achondrogenesis type IB (ACG1B; 600972) when compounded with a second structural mutation on the other chromosome, such as N425D (606718.0006).</Attribute>
              <Citation>
                <ID Source="PubMed">8528239</ID>
              </Citation>
              <XRef DB="OMIM" ID="600972" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a patient with atelosteogenesis type II (AO2; 256050), Hastbacka et al. (1996) identified compound heterozygosity for 1751delA and an 862C-T transition resulting in an R279W substitution (606718.0002) in the third extracellular loop.</Attribute>
              <Citation>
                <ID Source="PubMed">8571951</ID>
              </Citation>
              <XRef DB="OMIM" ID="256050" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC26A2" />
          </GeneList>
          <Name>SLC26A2, 1-BP DEL, 1751A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 1751A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="606718.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">DIASTROPHIC DYSPLASIA</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="50114" SubmissionDate="2015-04-06" DateLastUpdated="2015-04-08" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="606718.0001_ACHONDROGENESIS, TYPE IB" title="SLC26A2, 1-BP DEL, 1751A_ACHONDROGENESIS, TYPE IB" />
        <ClinVarAccession Accession="SCV000044858" DateUpdated="2015-04-08" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1996-02-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 3 patients with diastrophic dysplasia (DTD; 222600) from Germany, the Netherlands, and France, respectively, Hastbacka et al. (1994) identified heterozygosity for a deletion of 1 nucleotide in codon 575 of the DTD gene (SLC26A2), converting AAG to AG; this mutation resulted in a frameshift, causing a premature translational stop after 9 codons that would eliminate the last 20% of the protein. The deletion destroyed a DdeI site and created a BfaI site, providing a simple assay for the presence of the mutation. The patients presumably carried a different DTD mutation on the other homolog. Examination of 100 normal chromosomes confirmed that the deletion was not a polymorphism.</Attribute>
              <Citation>
                <ID Source="PubMed">7923357</ID>
              </Citation>
              <XRef DB="OMIM" ID="222600" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Superti-Furga et al. (1996) found that this mutation, which they called the 1751A deletion, results in diastrophic dysplasia when compounded with the presumed reduced-expression allele frequent in Finland (606718.0010), but produces achondrogenesis type IB (ACG1B; 600972) when compounded with a second structural mutation on the other chromosome, such as N425D (606718.0006).</Attribute>
              <Citation>
                <ID Source="PubMed">8528239</ID>
              </Citation>
              <XRef DB="OMIM" ID="600972" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a patient with atelosteogenesis type II (AO2; 256050), Hastbacka et al. (1996) identified compound heterozygosity for 1751delA and an 862C-T transition resulting in an R279W substitution (606718.0002) in the third extracellular loop.</Attribute>
              <Citation>
                <ID Source="PubMed">8571951</ID>
              </Citation>
              <XRef DB="OMIM" ID="256050" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC26A2" />
          </GeneList>
          <Name>SLC26A2, 1-BP DEL, 1751A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 1751A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="606718.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">ACHONDROGENESIS, TYPE IB</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="24470" SubmissionDate="2015-04-06" DateLastUpdated="2015-04-08" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="606718.0001_ATELOSTEOGENESIS, TYPE II" title="SLC26A2, 1-BP DEL, 1751A_ATELOSTEOGENESIS, TYPE II" />
        <ClinVarAccession Accession="SCV000024470" DateUpdated="2015-04-08" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1996-02-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 3 patients with diastrophic dysplasia (DTD; 222600) from Germany, the Netherlands, and France, respectively, Hastbacka et al. (1994) identified heterozygosity for a deletion of 1 nucleotide in codon 575 of the DTD gene (SLC26A2), converting AAG to AG; this mutation resulted in a frameshift, causing a premature translational stop after 9 codons that would eliminate the last 20% of the protein. The deletion destroyed a DdeI site and created a BfaI site, providing a simple assay for the presence of the mutation. The patients presumably carried a different DTD mutation on the other homolog. Examination of 100 normal chromosomes confirmed that the deletion was not a polymorphism.</Attribute>
              <Citation>
                <ID Source="PubMed">7923357</ID>
              </Citation>
              <XRef DB="OMIM" ID="222600" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Superti-Furga et al. (1996) found that this mutation, which they called the 1751A deletion, results in diastrophic dysplasia when compounded with the presumed reduced-expression allele frequent in Finland (606718.0010), but produces achondrogenesis type IB (ACG1B; 600972) when compounded with a second structural mutation on the other chromosome, such as N425D (606718.0006).</Attribute>
              <Citation>
                <ID Source="PubMed">8528239</ID>
              </Citation>
              <XRef DB="OMIM" ID="600972" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a patient with atelosteogenesis type II (AO2; 256050), Hastbacka et al. (1996) identified compound heterozygosity for 1751delA and an 862C-T transition resulting in an R279W substitution (606718.0002) in the third extracellular loop.</Attribute>
              <Citation>
                <ID Source="PubMed">8571951</ID>
              </Citation>
              <XRef DB="OMIM" ID="256050" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC26A2" />
          </GeneList>
          <Name>SLC26A2, 1-BP DEL, 1751A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 1751A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="606718.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">ATELOSTEOGENESIS, TYPE II</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3970113" SubmissionDate="2021-11-24" DateLastUpdated="2021-11-29" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="SUB10716300" submittedAssembly="hg19" title="SUB10716300" />
        <ClinVarAccession Accession="SCV002026485" DateUpdated="2021-11-29" DateCreated="2021-11-29" Type="SCV" Version="1" SubmitterName="Institute of Medical Genetics and Genomics, Sir Ganga Ram Hospital" OrgID="217613" OrganizationCategory="laboratory" OrgAbbreviation="Institute of Medical Genetics and Genomics" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-11-24">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">8528239</ID>
          </Citation>
          <Comment>The homozygous frameshift deletion variant c.1724delA has been previously reported as c.1751delA by Superti-Furga A et al in 1996 in a Dutch patient. The allele frequency-0.0048% in gnomAD (aggregated) database and 0.0058% in 1000g. Phenotype observed in the proband was cystic hygroma, generalized subcutaneous edema with skin thickening, hypoechogenic area and distorted fetal limbs. Achondrogensis IB is an autosomal recessive disorder. Based on the phenotypic observation and the available literature, we classify this variant as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>South East Asian</Ethnicity>
              <GeographicOrigin>India</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC26A2">
              <Name>solute carrier family 26 member 2</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000112.4:exon 3</GeneLocation>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000112.4:c.1724delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="600972" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10716300</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4076081" SubmissionDate="2022-02-09" DateLastUpdated="2022-04-23" DateCreated="2022-04-23">
        <ClinVarSubmissionID localKey="NM_000112.4:c.1724del|Achondrogenesis type IB" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002081861" DateUpdated="2022-04-23" DateCreated="2022-04-23" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-10-15">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000112.4:c.1724del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Achondrogenesis type IB</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10993736</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5017543" SubmissionDate="2022-08-23" DateLastUpdated="2022-08-29" DateCreated="2022-08-29">
        <ClinVarSubmissionID localKey="2022-04718|MONDO:0003900" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002567001" DateUpdated="2022-08-29" DateCreated="2022-08-29" Type="SCV" Version="1" SubmitterName="Genome Diagnostics Laboratory, The Hospital for Sick Children" OrgID="1043" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-05-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC26A2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000112.3:c.1724delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0003900" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11964009</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1361769" SubmissionDate="2018-01-25" DateLastUpdated="2018-03-17" DateCreated="2018-03-17">
        <ClinVarSubmissionID localKey="NM_000112.3:c.1724delA|MedGen:C0029422" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000695417" DateUpdated="2018-03-17" DateCreated="2018-03-17" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-01-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">8571951</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8528239</ID>
          </Citation>
          <Comment>Variant summary: The SLC26A2 c.1724delA (p.Lys575Serfs) variant results in a premature termination codon, predicted to cause a truncated or absent SLC26A2 protein due to nonsense mediated decay, which are commonly known mechanisms for disease. One in silico tool predicts a damaging outcome for this variant. This variant is absent in 121446 control chromosomes. This variant has been reported in multiple affected individuals and classified as pathogenic/likely pathogenic by clinical diagnostic laboratories and reputable databases. Taken together, this variant is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
            <CitationText>LabCorp Variant Classification Summary - May 2015.docx</CitationText>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC26A2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <XRefList>
            <XRef DB="dbSNP" ID="386833498" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000112.3:c.1724delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0029422" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2016-2017-variants</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5462701" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_000112.4:c.1724del|OMIM:222600;226900;256050;600972" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002805764" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-08-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000112.4:c.1724del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="222600" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="226900" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="256050" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="600972" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1852351" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="4572854|MedGen:C1850554;C1847593;C0265274;C0220726" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000958092" DateUpdated="2024-02-28" DateCreated="2019-08-14" Type="SCV" Version="6" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">7923357</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8528239</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8571951</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Lys575Serfs*10) in the SLC26A2 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 165 amino acid(s) of the SLC26A2 protein. This variant is present in population databases (rs749382145, gnomAD 0.008%). This premature translational stop signal has been observed in individual(s) with achondrogenesis, atelosteogenesis, and diastrophic dysplasia (PMID: 7923357, 8528239, 8571951; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 4087). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC26A2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000005.9:g.149360879del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1850554" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1847593" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0265274" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0220726" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7859303" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000112.4:c.1724del|OMIM:600972" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004201736" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000112.4:c.1724del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="600972" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1852351" TraitType="Disease" MappingType="XRef" MappingValue="C1847593" MappingRef="MedGen">
        <MedGen CUI="C1847593" Name="Multiple epiphyseal dysplasia type 4" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1361769" TraitType="Disease" MappingType="XRef" MappingValue="C0029422" MappingRef="MedGen">
        <MedGen CUI="C0029422" Name="Osteochondrodysplasia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5462701" TraitType="Disease" MappingType="XRef" MappingValue="222600" MappingRef="OMIM">
        <MedGen CUI="C0220726" Name="Diastrophic dysplasia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5462701" TraitType="Disease" MappingType="XRef" MappingValue="600972" MappingRef="OMIM">
        <MedGen CUI="C0265274" Name="Achondrogenesis, type IB" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="131219" TraitType="Disease" MappingType="Name" MappingValue="Diastrophic dysplasia" MappingRef="Preferred">
        <MedGen CUI="C0220726" Name="Diastrophic dysplasia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4076081" TraitType="Disease" MappingType="Name" MappingValue="Achondrogenesis type IB" MappingRef="Preferred">
        <MedGen CUI="C0265274" Name="Achondrogenesis, type IB" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7859303" TraitType="Disease" MappingType="XRef" MappingValue="600972" MappingRef="OMIM">
        <MedGen CUI="C0265274" Name="Achondrogenesis, type IB" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1852351" TraitType="Disease" MappingType="XRef" MappingValue="C1850554" MappingRef="MedGen">
        <MedGen CUI="C1850554" Name="Atelosteogenesis type II" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="24468" TraitType="Disease" MappingType="Name" MappingValue="DIASTROPHIC DYSPLASIA" MappingRef="Preferred">
        <MedGen CUI="C0220726" Name="Diastrophic dysplasia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5462701" TraitType="Disease" MappingType="XRef" MappingValue="226900" MappingRef="OMIM">
        <MedGen CUI="C1847593" Name="Multiple epiphyseal dysplasia type 4" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3970113" TraitType="Disease" MappingType="XRef" MappingValue="600972" MappingRef="OMIM">
        <MedGen CUI="C0265274" Name="Achondrogenesis, type IB" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1852351" TraitType="Disease" MappingType="XRef" MappingValue="C0220726" MappingRef="MedGen">
        <MedGen CUI="C0220726" Name="Diastrophic dysplasia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="50114" TraitType="Disease" MappingType="Name" MappingValue="ACHONDROGENESIS, TYPE IB" MappingRef="Alternate">
        <MedGen CUI="C0265274" Name="Achondrogenesis, type IB" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5017543" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0003900" MappingRef="MONDO">
        <MedGen CUI="C0009782" Name="Connective tissue disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5462701" TraitType="Disease" MappingType="XRef" MappingValue="256050" MappingRef="OMIM">
        <MedGen CUI="C1850554" Name="Atelosteogenesis type II" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1852351" TraitType="Disease" MappingType="XRef" MappingValue="C0265274" MappingRef="MedGen">
        <MedGen CUI="C0265274" Name="Achondrogenesis, type IB" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="24470" TraitType="Disease" MappingType="Name" MappingValue="ATELOSTEOGENESIS, TYPE II" MappingRef="Alternate">
        <MedGen CUI="C1850554" Name="Atelosteogenesis type II" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

